Daniela Lulli Selected Research

Antibodies

1/2023

Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Lulli Research Topics

Disease

5	Carcinogenesis 03/2023 - 01/2013
5	Neoplasms (Cancer) 01/2023 - 11/2012
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 05/2011
3	Inflammation (Inflammations) 01/2022 - 08/2011
1	Melanoma (Melanoma, Malignant) 01/2023
1	Vitiligo 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Edema (Dropsy) 09/2018
1	Contact Dermatitis (Eczema, Contact) 09/2018
1	Sarcoma (Soft Tissue Sarcoma) 10/2017
1	Wounds and Injuries (Trauma) 02/2012
1	Necrosis 08/2009

Drug/Important Bio-Agent (IBA)

4	ResveratrolIBA 09/2018 - 02/2012
4	PolyphenolsIBA 09/2018 - 08/2009
3	Interferon Type IIBA 09/2018 - 07/2016
3	ErbB Receptors (EGF Receptor)IBA 10/2017 - 06/2014
3	AntioxidantsIBA 02/2012 - 08/2009
2	QuercetinIBA 09/2018 - 02/2012
2	ChemokinesIBA 02/2012 - 08/2009
1	ceric oxide (cerium dioxide)IBA 03/2023
1	AntibodiesIBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	Apoptosis Regulatory ProteinsIBA 01/2023
1	NucleophosminIBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2020
1	Cetuximab (Erbitux)FDA Link 09/2018
1	DinitrofluorobenzeneIBA 09/2018
1	Gefitinib (Iressa)FDA Link 09/2018
1	HaptensIBA 09/2018
1	cobimetinibIBA 10/2017
1	dabrafenibIBA 10/2017
1	VemurafenibIBA 10/2017
1	trametinibIBA 10/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2017
1	Humanized Monoclonal AntibodiesIBA 07/2016
1	LigandsIBA 06/2014
1	Superoxides (Superoxide)IBA 02/2012
1	polydatinIBA 02/2012
1	Rutin (Rutoside)IBA 02/2012
1	acteosideIBA 02/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2011
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2011
1	Recombinant ProteinsIBA 05/2011
1	efalizumab (Raptiva)FDA Link 05/2011
1	CytokinesIBA 05/2011
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2011
1	EnzymesIBA 05/2011

Therapy/Procedure

2	Therapeutics 01/2023 - 05/2011
1	Immunotherapy 01/2023